The mechanisms by which CSMD1 variants may influence drug dependence liability are unknown and likely to be a part of broader effects on brain function as CSMD1 markers have been associated with schizophrenia [143], autism [144], bipolar disorder [145], and general cognitive ability and executive function [146]. Here, CSMD1 is linked to schizophrenia.